Navigation Links
KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
Date:3/25/2008

cal and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (5) new product development and launch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (6) reliance on key strategic alliances; (7) the availability of raw materials and/or products manufactured for the Company under contract manufacturing arrangements with third parties; (8) the regulatory environment, including regulatory agency and judicial actions and changes in applicable law or regulations; (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements by the Company's customers; (12) the impact of competitive response to the Company's sales, marketing and strategic efforts; (13) risks that the Company may not ultimately prevail in litigation; (14) the completion of the Company's financial statements for the first, second and third quarters of fiscal 2008; (15) actions by the Securities and Exchange Commission and the Internal Revenue Service with respect to the Company's stock option grants and accounting practices; (16) the risks detailed from time to time in the Company's filings with the Securities and Exchange Commission; and (17) the impact of credit market disruptions on the fair value of auct
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
2. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
3. Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance
4. Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer
5. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
6. Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX)
7. Alseres Pharmaceuticals, Inc. Raises $5 Million
8. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated
11. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013 According to the new ... Global Forecasts (2011 - 2016)” published by MarketsandMarkets, global ... million by the end of year 2010 and is ... a CAGR of 17.9% from 2011 to 2016. , ... , 44 Figures , 370 ...
(Date:5/24/2013)... Just about any bodyweight training program includes a ... based in Dallas, GA that uses a variety of bodyweight ... is not used enough. , “The medicine ball pushup ... more challenging. By keeping your hands on a medicine ball, ... being worked much harder than a standard pushup. This unique ...
(Date:5/24/2013)... May 24, 2013 Child safety expert ... tips for end-of-year gifts for teachers that can "show ... child's life." Van der Zande is the founder of ... and resources, whose mission is to help people create ... , "Teachers have an incredible impact on the emotional ...
(Date:5/24/2013)... 2013 Patients who have chronic cough ... suffer from gastroesophageal reflux disease or GERD, West ... study published today. , The article, “Antireflux Surgery in ... Measured by Hypopharyngeal Multichannel Intraluminal Impedance” appears in ... great importance to individuals who live with a nagging ...
(Date:5/24/2013)... May 24, 2013 BroadConnect Telecom, ... video, data, and IT security solutions, present small ... communication costs by more than fifty percent (when ... Time Hosted PBX Bundle Pricing. BroadConnect’s hosted Voice ... touch with VoIP. , Starting today, until the ...
Breaking Medicine News(10 mins):Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 2Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 3Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 4Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:BroadConnect Is Offering New Hosted PBX Bundle Pricing for New Customers, Eliminating VoIP Adoption Barriers 2
... MONDAY, April 23 (HealthDay News) -- The experience of killing ... a study of U.S. veterans of the Vietnam War. ... sample of Vietnam War veterans and found that those with ... thoughts as those with fewer or no experiences of killing. ...
... (HealthDay News) -- The shingles vaccine is generally safe and ... Shingles, which affects more than 1 million people each year ... by the dormant chickenpox virus, which can reactivate and replicate, ... risk because immunity against the virus that causes shingles declines ...
... By Randy Dotinga HealthDay Reporter , MONDAY, ... a type of overactive thyroid condition appears to boost ... form of irregular heartbeat) and premature death. Patients ... known as subclinical hyperthyroidism, because it often doesn,t cause ...
... and Damon could be the kids up the block. Briana ... sister,s footsteps to college. Damon works hard at an after-school ... and try to stay out of trouble. , But Briana ... are a pair of digitally animated street-smart characters with a ...
... INDIANAPOLIS -- WellPoint announced today that Indiana University ... clinical expertise to help shape WellPoint,s new health ... to develop commercial applications utilizing IBM Watson to ... their efforts to make the most informed, personalized ...
... of the screw. That,s just a part of life for ... distraction osteogenesis, a method to correct bone deformities that leave ... Rice University undergraduates has invented a device they hope will ... Shriners Hospital for Children in Houston, the students came up ...
Cached Medicine News:Health News:Wartime Killing May Raise Veterans' Thoughts of Suicide 2Health News:Shingles Vaccine Safe, Underutilized, Study Says 2Health News:Thyroid Condition Linked to Heart Problems: Study 2Health News:Thyroid Condition Linked to Heart Problems: Study 3Health News:Animated characters keep it real in teen violence prevention videos 2Health News:Animated characters keep it real in teen violence prevention videos 3Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 2Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 3Health News:Rice University student engineers automate limb lengthening for kids 2Health News:Rice University student engineers automate limb lengthening for kids 3
(Date:5/24/2013)... May 24, 2013 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China ... learned from a public announcement issued by Shanghai RAAS ... listed on Shenzhen Stock Exchange, that on May 21, ... ("Ms. Chan"), one of the shareholders of the Company, ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Deutsche Bank Health Care Conference ... Waterfront Hotel.  Mr. Adrian Adams , ... an overview of the Company and its product pipeline ...   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... -- In accordance with Rule 17.1 and Rule 2.9 of ... States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today ... ELN). Background On 2 May 2013, ... the entire of the issued and to be issued share ... On 20 May 2013, Royalty Pharma announced the ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9
... Codexis, Inc. (Nasdaq: CDXS ) today announced the company ... held in New York, NY on February 23-24, 2011. The presentation ... The company will also present at the Pacific Crest ... March 1-2, 2011. The presentation is scheduled for March 1 at ...
... 8, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... subsidiary, Biovail Laboratories International SRL (BLS), has entered into ... (dapsone) Gel 5%, a topical formulation of dapsone used ... will receive from BLS a CA$500,000 upfront payment to ...
Cached Medicine Technology:Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada 2Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada 3
Rhoton #12 straight point needle semisharp, titanium....
Micro 2000, micro scissors micro 2000 supercut....
Micro 2000 suture forceps light-weight instruments with blue-colored anodized round handles, extremely light weight, well balanced, easy to handle, fatigueless working, easy to maintain, corrosion-re...
Mini blades....
Medicine Products: